ImmunityBio, Inc.
IBRX
$2.84
$0.176.37%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.59M | 149.81M | 130.37M | 217.98M | 170.50M |
| Total Receivables | 17.45M | 2.65M | 4.90M | 2.06M | 2.14M |
| Inventory | 8.44M | 8.27M | 1.96M | 1.81M | -- |
| Prepaid Expenses | 13.62M | 16.73M | 15.21M | 11.33M | 11.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.05M | 7.12M | 10.71M | 9.65M | 11.82M |
| Total Current Assets | 109.16M | 184.59M | 163.15M | 242.83M | 195.72M |
|
|
|||||
| Total Current Assets | 109.16M | 184.59M | 163.15M | 242.83M | 195.72M |
| Net Property, Plant & Equipment | 167.05M | 170.46M | 174.23M | 175.79M | 178.75M |
| Long-term Investments | 910.00K | 910.00K | 910.00K | -- | -- |
| Goodwill | 910.00K | 910.00K | 910.00K | -- | -- |
| Total Other Intangibles | 14.53M | 15.02M | 15.57M | 16.06M | 16.57M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.40M | 11.96M | 10.71M | 9.65M | 9.63M |
| Total Assets | 303.76M | 382.93M | 364.57M | 444.33M | 400.68M |
|
|
|||||
| Total Accounts Payable | 13.50M | 6.73M | 9.95M | 20.32M | 13.87M |
| Total Accrued Expenses | 25.59M | 37.91M | 39.70M | 33.88M | 30.68M |
| Short-term Debt | -- | 1.25M | 2.16M | -- | 596.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.46M | 7.47M | 7.03M | 6.27M | 6.13M |
| Total Finance Division Other Current Liabilities | 2.66M | 1.60M | 2.12M | 1.65M | 2.49M |
| Total Other Current Liabilities | 2.66M | 1.60M | 2.12M | 1.65M | 2.49M |
| Total Current Liabilities | 49.21M | 54.94M | 60.96M | 62.11M | 53.76M |
|
|
|||||
| Total Current Liabilities | 49.21M | 54.94M | 60.96M | 62.11M | 53.76M |
| Long-Term Debt | 782.00M | 746.28M | 972.78M | 956.26M | 850.50M |
| Short-term Debt | -- | 1.25M | 2.16M | -- | 596.00K |
| Capital Leases | 33.10M | 34.82M | 36.76M | 36.43M | 38.20M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 29.94M | 35.01M | 38.24M | 86.91M | 149.20M |
| Total Liabilities | 894.24M | 871.06M | 1.11B | 1.14B | 1.09B |
|
|
|||||
| Common Stock & APIC | 2.89B | 2.88B | 2.57B | 2.53B | 2.40B |
| Retained Earnings | -3.50B | -3.38B | -3.32B | -3.23B | -3.10B |
| Treasury Stock & Other | 19.96M | 1.20M | 103.00K | -8.00K | -7.00K |
| Total Common Equity | -591.43M | -489.10M | -745.15M | -698.39M | -692.01M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -591.43M | -489.10M | -745.15M | -698.39M | -692.01M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 949.00K | 969.00K | 986.00K | 1.01M | 1.03M |
| Total Equity | -590.48M | -488.13M | -744.16M | -697.38M | -690.98M |
|
|
|||||